Cargando…

Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia

The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajner, Fanni, Hadaya, Laila, McQueen, Grant, Sendt, Kyra-Verena, Gillespie, Amy, Avila, Alessia, Lally, John, Hedges, Emily P., Diederen, Kelly, Howes, Oliver D., Barker, Gareth J., Lythgoe, David J., Kempton, Matthew J., McGuire, Philip, MacCabe, James H., Egerton, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891256/
https://www.ncbi.nlm.nih.gov/pubmed/35236831
http://dx.doi.org/10.1038/s41537-022-00230-2
_version_ 1784661831106691072
author Krajner, Fanni
Hadaya, Laila
McQueen, Grant
Sendt, Kyra-Verena
Gillespie, Amy
Avila, Alessia
Lally, John
Hedges, Emily P.
Diederen, Kelly
Howes, Oliver D.
Barker, Gareth J.
Lythgoe, David J.
Kempton, Matthew J.
McGuire, Philip
MacCabe, James H.
Egerton, Alice
author_facet Krajner, Fanni
Hadaya, Laila
McQueen, Grant
Sendt, Kyra-Verena
Gillespie, Amy
Avila, Alessia
Lally, John
Hedges, Emily P.
Diederen, Kelly
Howes, Oliver D.
Barker, Gareth J.
Lythgoe, David J.
Kempton, Matthew J.
McGuire, Philip
MacCabe, James H.
Egerton, Alice
author_sort Krajner, Fanni
collection PubMed
description The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity.
format Online
Article
Text
id pubmed-8891256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88912562022-03-17 Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia Krajner, Fanni Hadaya, Laila McQueen, Grant Sendt, Kyra-Verena Gillespie, Amy Avila, Alessia Lally, John Hedges, Emily P. Diederen, Kelly Howes, Oliver D. Barker, Gareth J. Lythgoe, David J. Kempton, Matthew J. McGuire, Philip MacCabe, James H. Egerton, Alice Schizophrenia (Heidelb) Article The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity. Nature Publishing Group UK 2022-03-02 /pmc/articles/PMC8891256/ /pubmed/35236831 http://dx.doi.org/10.1038/s41537-022-00230-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Krajner, Fanni
Hadaya, Laila
McQueen, Grant
Sendt, Kyra-Verena
Gillespie, Amy
Avila, Alessia
Lally, John
Hedges, Emily P.
Diederen, Kelly
Howes, Oliver D.
Barker, Gareth J.
Lythgoe, David J.
Kempton, Matthew J.
McGuire, Philip
MacCabe, James H.
Egerton, Alice
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
title Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
title_full Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
title_fullStr Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
title_full_unstemmed Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
title_short Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
title_sort subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891256/
https://www.ncbi.nlm.nih.gov/pubmed/35236831
http://dx.doi.org/10.1038/s41537-022-00230-2
work_keys_str_mv AT krajnerfanni subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT hadayalaila subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT mcqueengrant subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT sendtkyraverena subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT gillespieamy subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT avilaalessia subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT lallyjohn subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT hedgesemilyp subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT diederenkelly subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT howesoliverd subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT barkergarethj subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT lythgoedavidj subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT kemptonmatthewj subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT mcguirephilip subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT maccabejamesh subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia
AT egertonalice subcorticalvolumereductionandcorticalthinning3monthsafterswitchingtoclozapineintreatmentresistantschizophrenia